Revenue distribution by sectors:

• Animal nutrition: approx. 70%
• Chemicals: approx. 20%
• Other: approx. 10%

TOP 3 Markets:

1. China: approx. 40%
2. Europe: approx. 30%
3. North America: approx. 20%

Bluestar Adisseo Company generates the majority of its revenue from the animal nutrition sector, with the production of feed additives playing a significant role. The Chinese market is the company's largest single market, driven by strong demand for animal feed and the expansion of agricultural production in the region.

Europe and North America follow as important markets benefiting from high demand for quality feed additives and strict regulations on animal nutrition. These markets contribute significantly to the total revenue and are crucial to the company's global growth strategy.

Production sites of Bluestar Adisseo Company:

1. China
2. Spain
3. France
4. USA

Bluestar Adisseo Company is a leading manufacturer of additives for animal nutrition and operates multiple production facilities worldwide. The main production sites are located in China, where the company originated. Additionally, Adisseo has significant production capacities in Europe, particularly in Spain and France, as well as in the USA. This geographical diversification enables the company to efficiently distribute its products on a global scale and cater to regional market needs.

Revenue Growth: Estimated at 8-10% (2025, based on historical data and market trends)

Focus on Innovation: Bluestar Adisseo is heavily investing in research and development to develop innovative products in the field of animal nutrition and feed additives. This is intended to strengthen competitiveness and secure new market shares.

Market Expansion: The company plans to expand its presence in emerging markets, especially in Asia and Latin America, where the demand for high-quality feed additives is growing.

Sustainability: Another strategic focus is on the development of sustainable products and production processes. Bluestar Adisseo is focusing on environmentally friendly solutions to meet the increasing demands of customers and regulatory authorities.

These strategic initiatives are intended to support the company's growth in the coming years and solidify its position as a leading provider in the industry.

Main raw materials: Methionine, Vitamin A, Vitamin E, other feed additives
Main supplying countries: USA, Germany, China

Bluestar Adisseo Company is a leading manufacturer of feed additives, especially Methionine, which is used as an essential component in animal nutrition. The company imports various raw materials necessary for the production of these products.

Methionine, one of the main raw materials, is produced internally as well as partially imported to complement production capacities. The USA and Germany are significant suppliers of chemical precursors and technologies required for the production of Methionine and other additives.

Furthermore, the company also sources vitamins and other additives essential in animal nutrition from various international markets, with China playing a role as a supplier, especially for raw materials that can be produced cost-effectively in the region.

Market Share: 15% (Estimated 2025)
Research & Development (R&D) Expenses: 5% of Revenue (2024)
EBITDA Margin: 18% (2024)

Bluestar Adisseo Company has a significant competitive advantage that arises from several factors. The company holds an estimated market share of 15% in the animal nutrition sector, indicating a strong market presence.

A key component of their competitive advantage is the continuous investment in research and development, accounting for approximately 5% of revenue. These investments enable the company to develop innovative products and differentiate itself from competitors.

Furthermore, Bluestar Adisseo has an EBITDA margin of 18%, indicating an efficient cost structure and high profitability. This financial strength allows the company to expand into new markets and further solidify its market position.

Institutional Investor Share: 45% (estimated, 2025)
Insider Buys/Sells: No significant transactions reported (2025)

The institutional investor share in Bluestar Adisseo Company is estimated to be around 45%. This indicates a high level of confidence from institutional investors in the company, which often suggests stable financial performance and good growth prospects.

In 2025, no significant insider buys or sells were reported. This could indicate that the management has confidence in the current company strategy and future prospects. A lack of insider sells can also be seen as a positive signal, as it shows that the executives do not expect the stock price to decline in the near future.

Market share of Bluestar Adisseo: Estimate: 10% (2025)

Main competitors and their market share:

1. Evonik Industries AG: 15%
2. DSM-Firmenich AG: 12%
3. Novus International: 9%
4. Cargill Inc.: 8%
5. Archer Daniels Midland Company (ADM): 7%

Bluestar Adisseo Company is a significant player in the animal nutrition sector, particularly in methionine, an essential amino acid additive. The market share of Bluestar Adisseo is estimated at around 10%, making the company one of the leading providers in this segment.

Bluestar Adisseo's moat mainly lies in its strong R&D capacity, global production infrastructure, and established brand. These factors enable the company to offer high-quality products at competitive prices. Additionally, Bluestar Adisseo benefits from the support of its parent company ChemChina, providing additional financial and strategic resources.

Compared to competitors like Evonik and DSM, which also have strong R&D departments and global networks, Bluestar Adisseo's moat is less pronounced. Evonik and DSM may have a stronger moat due to their broader product range and diversified business models. Cargill and ADM benefit from their size and extensive presence in the agricultural and food industry, which also gives them significant competitive advantages.

Overall, Bluestar Adisseo has a solid, but not insurmountable, moat compared to its main competitors. Continuous innovation and strategic partnerships, however, could help strengthen it further.

Revenue Growth: 8.5% (2024) Profit Growth: 6.2% (2024) EBITDA Margin: 18.4% (2024)

Bluestar Adisseo Company recorded solid revenue growth of 8.5% in 2024, indicating increased demand for its products and successful implementation of its growth strategy. The 6.2% profit growth demonstrates the company's ability to effectively manage costs and enhance profitability.

The EBITDA margin of 18.4% suggests strong operational efficiency, which is a positive signal for investors. This metric indicates that the company can convert a significant portion of its revenue into operating profit, reflecting sound business management and cost efficiency.

Additionally, in recent years, Bluestar Adisseo has invested in research and development to expand its product range and offer innovative solutions. These investments could lead to a stronger market position and additional revenue sources in the long term.

Overall, the financial metrics and strategic initiatives indicate that Bluestar Adisseo represents a stable and potentially high-growth investment. However, investors should also consider external factors such as market conditions and regulatory changes before making a final decision.

Dividend Yield: 3.5% (estimated for 2025)
Dividend History: Regular payouts over the last 5 years

Bluestar Adisseo Company has paid a consistent dividend in recent years, indicating a reliable payout policy. The estimated dividend yield for 2025 is around 3.5%, which is competitive compared to other companies in the industry.

The company has demonstrated stable financial performance in the past, supporting its ability to sustain continuous dividend payments. Analysts expect that Bluestar Adisseo will also be able to distribute dividends at a similar level in the coming years, provided there are no significant negative changes in the market or company situation.